NCT06411223Active, not recruitingPhase 2
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Project Tara: Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This study addresses real-world use of long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) by evaluating implementation and clinical outcomes of a pharmacist-led collaborative drug therapy management model (CDTM+) that will be expanded for telehealth outreach to women with health-related social needs (HRSN).
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 7 May 2024
- Start date
- 1 Aug 2024
- Primary completion date
- Mar 2027
- Lead sponsor
- Yale University
- Diseases
- HIV
- NCT number
- NCT06411223
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 50
- From 1 Aug 2024 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have initiated CAB/RPV oral lead-in prior to enrollment.
Other
- Unable or unwilling to complete informed consent (e.g., have a conservator of person)
- Have a contraindication to CAB/RPV LA per label.
- Have known or suspected resistance to CAB/RPV
- Pregnant or breast-feeding
Who the study is looking for
- Living with diagnosed HIV
- Receiving HIV care-related services from Yale New Haven Health (YNHH)
- Currently on oral ART and virally suppressed for at least 6 months (from electronic health review).
- Have experienced at least one HRSN: a) homelessness or housing insecurity; b) food insecurity; c) criminal legal system involvement; OR d) substance use in the past 3 years (from self-report at screening).
- Able to converse comfortably in English or Spanish
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale Clinical and Community Research Coordinator of this site? Confirm its status | New Haven | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.